Fresenius Medical Care AG (FMEd)

FRAHealthcare

€39.39
+€0.71 (+1.9%)

April 7, 2026 at 09:21 UTC

Interactive Chart

FMEd
1H
3H
6H
12H
1D
1W
1M
3M
6M
1Y
2Y
5Y
All

09:21:40 UTC

About Fresenius Medical Care AG

Name
Fresenius Medical Care AG
CEO
Helen Giza
Industry
Healthcare
Employees
112,035

Fresenius Medical Care AG delivers kidney-care services and therapy systems used in routine clinical practice. The company runs treatment networks and manufactures equipment under one quality framework designed for repeatable care. Its model pairs clinic operations with product supply, so planning for capacity and logistics sits alongside validation and field support. Activity is global and concentrated in regulated healthcare systems. Over time the business expanded its installed base and clinic footprint while standardizing documentation, training, and service procedures. Clinical software supports scheduling and outcome tracking, and governance keeps patient safety and data integrity central to decisions. Within the healthcare sector, the company occupies the link between care delivery and the industries that supply and fund it, operating as a platform that moves patients from initiation to ongoing monitoring without breaking the record of care.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 1 Buy, 18 Hold, 4 Sell
Buy1
Hold18
Sell4

Fundamentals & Financials

Revenue (TTM)
€19.6B
Net Income (TTM)
€978.2M
EPS (TTM)
€3.37
ROA (TTM)
3.16%
Current Ratio
1.26
Dividend Yield
0.097%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ4 2025
Revenue€5,070M
Cost of Sales€3,681M
Gross Profit€1,389M
Operating Income€565,000K
Net Income€327,000K
EPS€1.14

Technical Indicators

Fresenius Medical Care AG's Technical Indicators Summary

FME presents a neutral picture with mixed short-term cues and a lack of conviction. Momentum metrics and the RSI are near neutral, the MACD is marginally negative, and the ADX shows only modest trend strength, leaving momentum muted. The very short EMA sits near the current price while longer EMAs lie above, producing balanced moving-average signals; volume and volatility metrics are not decisive and the pivot sits close to the trade level. Technical takeaway: Neutral — indicators are mixed and trend strength is limited, so no clear direction is established.

Buy
1 signal
Neutral
18 signals
Sell
4 signals
Overall: Neutral78% Neutral signals
IndicatorValue
RSI (14)
47.12
Stochastic %K (14, 3, 3)
CCI (20)
WPR (14)
Momentum (10)
MFI
44.73
MACD Level (12, 26)
-0.26
Bollinger Bands
ATR (14)
ADX (14)
20.85
OBV
Classic Pivot Point
$38.45
Fibonacci Pivot Point
$38.45
Exponential Moving Averages
$38.66 - $42.17(5 indicators)
Simple Moving Averages
(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

FMEd saw stable price action in the last session, ending the day nearly unchanged at 38.67. FMEd ends the session flat as broader markets consolidate in a tight range, keeping the stock near prior levels.

Price Change

from €38.67 close

+€0.73

Trading Volume

Below avg (704.2K)

100

vs S&P 500 Today

Moderate Underperformance

-0.44%

52-Week Position

Lower range

16.3%

Updated: April 7, 2026 at 07:10 UTC

Quote Summary

OpenPrevious Close
€38.17€38.67
Day Range52 Week Range
€38.01 - €38.67€35.67 - €54.02
VolumeAvg. Volume
651.4K964.8K
Market CapP/E Ratio
€11.2B11.5